Application
NEU1 Antibody (Center) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the NEU1 antibody detected the NEU1 protein (arrow).| Product Name | NEU1 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | NEU1; NANH; Sialidase-1; Acetylneuraminyl hydrolase; G9 sialidase; Lysosomal sialidase; N-acetyl-alpha-neuraminidase 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | NANH |
|---|---|
| Alternative Names | NEU1 NANH Sialidase-1 Acetylneuraminyl hydrolase G9 sialidase Lysosomal sialidase N-acetyl-alpha-neuraminidase 1 |
| Molecular Weight(MW) | 45467 Da |
| Function | Catalyzes the removal of sialic acid (N-acetylneuramic acid) moities from glycoproteins and glycolipids. To be active, it is strictly dependent on its presence in the multienzyme complex Appears to have a preference for alpha 2-3 and alpha 2-6 sialyl linkage |
| Tissue Specificity | Highly expressed in pancreas, followed by skeletal muscle, kidney, placenta, heart, lung and liver. Weakly expressed in brain |
| Cellular Localization | Lysosome membrane; Peripheral membrane protein; Lumenal side. Lysosome lumen. Cell membrane. Cytoplasmic vesicle. Note=Localized not only on the inner side of the lysosomal membrane and in the lysosomal lumen, but also on the plasma membrane and in intracellular vesicles |
| Entrez Gene | 4758 |
|---|---|
| Nucleotide Accession | NP_000425.1 |
Application
NEU1 Antibody (Center) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the NEU1 antibody detected the NEU1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
